Organochem is a Genesis Drug Discovery & Development (GD3) company based in Hungary, founded in 2009. The company specializes in supplying special synthons, building blocks, fragment-based library, and small, focused libraries to the pharmaceutical, biotechnology, and agrochemical industries. Their commitment lies in providing smart chemistry solutions to support the design of new drugs and bioactive products.
Organochem's last investment amounted to €71.43K as a grant from EASME - EU Executive Agency for SMEs on 01 September 2018. This investment reflects the recognition and support the company has received from respected entities, further validating its potential in the industry.